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Abstract:
Background: The achievement and preservation of an adequate amount 
of soft tissue around implants is a critical factor for the prognosis of the 
treatment. 
Purpose: To evaluate the effectiveness of a porcine dermal matrix 
applied during second stage implant surgery for horizontal soft tissue 
augmentation and preservation of dimensional stability. 
Material & Methods: Twenty patients (mean age 50.211.9 (standard 
deviation) years) candidate to implant therapy and requiring soft tissue 
augmentation were recruited in four centers. Augmentation was 
performed in 24 cases. A porcine dermal matrix was placed into a buccal 
split-thickness pouch during uncovering surgery. Silicone impressions 
were taken before surgery (T0), two weeks later at suture removal (T2), 
six months (T3) and 24 months (T4) post augmentation. Dimensional 
changes of soft tissue were evaluated using superimposition of 
digitalized study casts. 
Results: Nineteen patients (23 implants) could be evaluated at six 
months and 13 patients (17 implants) at 24 months. After 6-month 
follow-up there was a significant dimensional gain respect to baseline, 
averaging 0.830.64mm (p<0.01). This did not change significantly at 
24 months (0.770.65mm, p=0.19). The gain was >0.5 mm in 65.2% 
and 64.7% of the cases, respectively. Soft tissue shrinkage averaged 
34.2%77.0% from T2 to T3 (p<0.01) and did not change thereafter 
(p=0.39). Shrinkage was more consistent in the posterior mandible than 
in the maxilla, but not significantly (p=0.23 at 6-month and 0.36 at 24-
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month). No adverse events occurred. 
Conclusions: Within the limitations of this prospective case series, the 
use of a porcine dermal matrix may provide consistent soft tissue 
augmentation that maintains up to 24-month follow-up, though graft 
shrinkage may occur in the first 6 months, depending on the location of 
surgery. 
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Abstract
Background: The achievement and preservation of an adequate amount of soft tissue 
around implants is a critical factor for the prognosis of the treatment. 
Purpose: To evaluate the effectiveness of a porcine dermal matrix applied during 
second stage implant surgery for horizontal soft tissue augmentation and 
preservation of dimensional stability. 
Material & Methods: Twenty patients (mean age 50.211.9 (standard deviation) 
years) candidate to implant therapy and requiring soft tissue augmentation were 
recruited in four centers. Augmentation was performed in 24 cases. A porcine dermal 
matrix was placed into a buccal split-thickness pouch during uncovering surgery. 
Silicone impressions were taken before surgery (T0), two weeks later at suture 
removal (T2), six months (T3) and 24 months (T4) post augmentation. Dimensional 
changes of soft tissue were evaluated using superimposition of digitalized study 
casts.
Results: Nineteen patients (23 implants) could be evaluated at six months and 13 
patients (17 implants) at the end of the study24 months. After 6-month follow-up 
there was a significant dimensional gain respect to baseline, averaging 0.830.64mm 
(p<0.01). This did not change significantly at 24 months (0.770.65mm, p=0.19). The 
gain was >0.5 mm in 65.2% and 64.7% of the cases, respectively. Soft tissue 
shrinkage averaged 34.2%77.0% from T2 to T3 (p<0.01) and did not change 
thereafter (p=0.39). Shrinkage was more consistent in the posterior mandible than in 
the maxilla, but not significantly (p=0.23 at 6-month and 0.36 at 24-month). No 
adverse events occurred. 
Conclusions: Within the limitations of this prospective case series, the use of a 
porcine dermal matrix may provide consistent soft tissue augmentation that maintains 
up to 24-month follow-up, though graft shrinkage may occur in the first 6 months, 
depending on the location of surgery. 
Keywords: gingival thickness, acellular dermal matrix, second stage surgery, dental 
implant, soft tissue augmentation
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Introduction
Dental implants show high survival and success rates on the implant level in fully and 
partially edentulous patients.1-3 Osseointegration and peri-implant soft tissue stability 
are important factors to achieve predictable long-term outcomes. The amount of soft 
tissue volume may improve the aesthetics and partially compensate for missing bone 
on the buccal aspect of dental implants.4-5
Soft tissue augmentation surgery can be performed at different stages of the implant 
therapy.5-11 In general, the use of subepithelial connective tissue grafts (SCTG) 
harvested from the palate is considered the gold standard for soft tissue 
augmentation around dental implants.12-14 However, the harvesting procedure with 
the second surgical site increases treatment time and patient morbidity. Therefore, 
current research focuses on alternative techniques and materials. A porcine acellular 
dermal collagen matrix has been introduced as an alternative to SCTGs in order to 
avoid surgical risks and to decrease patient morbidity.15-19 These matrices proved 
their ability to increase soft tissue thickness in preclinical animal studies.20-22 In a 
comparative dog study a porcine collagen matrix has shown similar results as SCTG 
after a 10-month follow-up.21 Preclinical studies suggested that acellular dermal 
matrices may represent a suitable scaffold for three-dimensional soft tissue 
thickening, showing good biocompatibility and appropriate biodegrading features.23 
Collagen-based dermal matrices have shown good clinical integration in plastic 
periodontal surgery24,25 and implant surgery.26,27 Linkevicius et al. showed in a clinical 
study that mucosa thickness can be increased predictably with an acellular dermal 
matrix of allogenic origin in the molar region.28 
Today, the use of collagen matrices as an alternative to SCTGs for the correction of 
localized ridge defects around dental implants cannot be recommended clinically, 
due to insufficient evidence regarding the effectiveness of the method in providing 
suitable three-dimensional tissue dimension and long-term stability.5,12
The aim of the present multicenter study was to test the effectiveness of a porcine 
acellular dermal matrix, applied at the time of second stage surgery, in providing 
adequate soft tissue augmentation at the buccal aspect, up to 24-month follow-up. 
The working hypothesis was that using a porcine acellular dermal matrix buccally 
positioned, soft tissue volume can be increased predictably, achieving and 
maintaining a horizontal gain of at least 0.5 mm.
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Materials and Methods
Study design
The Witten/Herdecke University´s Ethical Committee of the Medical Faculty approved 
the consent form and study protocol (18/2015). Subjects were enrolledtreated at four 
different University clinical centres between May and November 2015. Three clinics 
were located in Germany (Witten/Herdecke University (K.F.), Private practice in 
München (H.W.)München, Private practice in Münster (A.H.) & Witten), Germany; 
and one in Italy (Private practice in Como (T.T.)Milan, Italy). In total, four surgeons 
(one per each centre) performed the interventions. All of them were highly skilled and 
equally trained, with more than 10 years of experience in implant dentistry and tissue 
augmentation procedures. Specific clinical procedures and instructions for handling 
of all materials used in this study were thoroughly reviewed in a preliminary meeting 
in the presence of the four surgeons. The study started only when all surgeons 
declared they were comfortable with the operative procedures of the surgical and 
prosthetic protocol. 
between May and November 2015. Within this prospective case series, 20 patients 
(5 patients per center) in need of minor soft tissue volume augmentation during 
second stage surgery were to be enrolled after thorough explanation of the study and 
after signing informed consent. The following inclusion and exclusion criteria were 
applied:
Inclusion Criteria:
(1) partially edentulous patients scheduled for fixed implant-supported 
rehabilitation;
(2) implant treatment was performed with a two-piece implant system (bone-level 
implant);
(3) implants underwent submerged healing;
(4) minor localized buccal ridge contour deficiency (less than 1 mm defect, 
clinically estimated), with no exposure of the implant surface.
Exclusion Criteria:
(1) uncontrolled diabetes mellitus (HbA1c > 6.5%);
(2) pregnant or lactating women;
(3) infectious diseases (AIDS, Hepatitis B, C);
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(4) moderate or heavy smoking (> 10 cigarettes per day);
(5) untreated periodontitis;
(6) implants planned for a removable denture;
(7) immediate implants in fresh postextraction sockets.
Surgical Intervention (uncovering-second stage)
Anaesthesia was induced with 4% articaine chlorhydrate and epinephrine 
(1:100,000). After a crestal incision above the implant, a spilt-thickness flap was 
prepared to create a buccal pouch. A rehydrated, 2-mm thick acellular porcine 
dermal matrix (APDM; OsteoBiol Derma Standard, Tecnoss®, Giaveno, Italy) was 
placed into the recipient site as reported in an earlier study.29 Thereafter, a healing 
cap replaced the implant cover screw and the flap was readapted to fully cover the 
transplant using microsurgical sutures (6-0 Seralene, Serag Wiessner, Naila, 
Germany). In Fig.1 are shown pre-surgical, as well as intra-surgical images of one 
case, to illustrate positioning of th  matrix.
Each patient was instructed not to brush in the surgical area for 14 days and to rinse 
with 0.2% chlorhexidine digluconate three times per day. Furthermore, each patient 
was prescribed 600mg ibuprofen, to be taken as required.
Clinical measurements:
Silicone impressions of the whole jaw (Impregum, 3M Espe, Neuss, Germany) were 
taken directly before surgery (T0), at suture removal (14 days post-surgery; T2), after 
6 (T3) and 24 months (T4) of follow-up. At the end of surgery (T1) only clinical 
pictures were taken. The fixed prosthetic restoration was delivered 14 days after T2. 
There was no standardization regarding the prosthetic protocol: each center was free 
to choose the most appropriate fixed prosthetic restoration for each patient. In order 
to measure tissue contour changes, master casts were fabricated from dental stone 
casts (GC Fujirock type 4, GC Corp., Tokyo, Japan) using the pre-surgery and follow-
up impressions. The casts were then optically scanned with a CEREC scan utility 
(inEosX5, Sirona Dental Systems, Bensheim, Germany) resulting in digital STL files 
(Standard Tessellation Language). All study centers sent their impressions to 
Witten/Herdecke University, where all the scans were performed. One single expert 
evaluator (S.M.), unaware of the type of surgery performed, undertook all 
measurements.
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Dimensional analysis
The obtained digital images of the casts reflecting the different treatment time points 
(pre-surgery, 14 days post-surgically, 6 and 24 months post-surgically) were then 
transferred into another digital imaging software (Swissmeda/SMOP, Zürich, 
Switzerland). This software allowed the superimposition and matching of the different 
digital models. The best-fit algorithm was used to superimpose the digital surface 
models based on unchanged tooth structures as reference.
The area of interest at the buccal aspect of the study-specific implant was defined 
according to the technique published in previous studies.30-32 The mesial and distal 
papillary midline, the mucogingival line, and the crown margin served as anatomical 
reference structures. If necessary, the coronal area of interest was shifted 1-2 mm 
more apical to avoid non-readable measurements because of invalid 
superimposition. Consequently, in each patient the area of interest was of different 
size. To allow for a direct comparison between patients, the mean dimensional 
change per area was calculated, resulting in a linear buccal distance. Therefore, the 
study sites could be compared irrespective of their size and the size of the area of 
interest. Before the dimensional analysis, a calibration session was conducted to 
ensure reproducibility.
Outcome measures
Primary outcomes: 1. Horizontal ridge augmentation. It was considered successful 
when augmentation was greater than 0.5 mm in the horizontal dimension, respect to 
baseline (T0). Such value was arbitrarily taken, based on previous similar studies, 
that showed a considerable shrinking after initial augmentation.20,31 In the present 
study a net horizontal gain of 0.5 mm was considered clinically relevant. 
2. Graft horizontal shrinkage after six (T3) and 24 months (T4) of healing, as 
compared to the 2-week dimension (T2). 
Secondary outcomes: Incidence of adverse events following the surgical 
interventions defined as flap dehiscence, graft exfoliation or allergic reactions. 
Statistical analysis:
Descriptive statistics such as mean values, standard deviations, median and 
percentiles were calculated using the software SPSS Statistics 22 (IBM, Ehningen, 
Germany). The normality of the distributions was assessed by means of the 
D’Agostino and Pearson omnibus normality test. The differences in horizontal soft 
tissue gain between T2, T3 and T4, as well as in shrinkage at T3 and T4, was 
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assessed by means of Wilcoxon matched-pairs signed rank test. The difference in 
soft tissue shrinkage between regions (posterior maxilla vs posterior mandible) was 
assessed using the Mann Whitney test. The single case was considered as the unit 
of analysis. A p-value <0.05 was considered as statistically significant.
Results
Participant Flow
Subjects were enrolled at four different University clinical centres (München, Münster 
& Witten, Germany; Milan, Italy) between May and November 2015. In total, 20 
healthy patients were screened for eligibility, and gave their informed consent for 
participation in this study and were recruited. Each centre contributed with five 
patients. One participant was not available at T3 and other 6 participants were not 
available at T4 hence, they were excluded from the data analysis. 
All patients were of Caucasian ethnicity (10 female and 10 male), with an age 
ranging from 33 to 66 years (average: 50.311.9 (standard deviation, SD)). All 
participants were systemically and periodontally healthy and two were minor smokers 
(<10 cigarettes per day). Soft tissue augmentation was performed at 24 implants (11 
in the mandible and 13 in the maxilla), Twenty-four augmentations were performed 
but not all of them could be followed throughout the study.
Suture removal (T2). 
One patient (one implant) refused to continue the study and was considered drop-
out. In the remaining 19 patients, in four implants out of 23 (all in the posterior 
maxilla), the horizontal soft tissue gain at T2 could not be estimated due to 
inappropriate overlapping of the digital scan at T2 with the reference scan at T1. So, 
19 paired observations were available for statistical comparisons between different 
time frames at T2 (2 weeks). 
Six-month follow-up (T3)
One participant was not available at T3. (6-month follow-up) Nineteen subjects with a 
total of 23 implants were evaluated at the 6-month follow-up. The majority of implants 
(21/23) were located at premolar and molar level. Comparison with T1 was possible 
for all 23 cases.
Twenty-four-month follow-up
 and other 6Six more participants (six implants) were not available at T4 (24-month 
follow-up). hence,All of themThey were considered lost-to follow-up and they were 
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excluded from the final data analysis. Nineteen subjects with a total of 23 implants 
were evaluated at the 6-month follow-up andHence, 13 patients (17 implants) were 
evaluated at 24 months. The majority of implants (21/23 at 6 months and 15/17 at 24 
months) were located at premolar and molar level. Horizontal gain respect to T1 
could be correctly estimated at T4 in all 17 cases, but shrinkage could be calculated 
only for 14 cases matching with T2 measurements (5 in the mandible and 9 in the 
maxilla).
A clinical case is shown in Fig. 2a-d. Occlusal pictures of T0, T1, T2 and T3 are 
shown. The digital analysis of the same case, followed up to 24 months, is shown in 
Fig. 3.
In four cases out of 23 (all in the posterior maxilla), the horizontal soft tissue gain at 
T2 could not be estimated due to inappropriate overlapping of the digital scan at T2 
with the reference scan at T1. So, 19 paired observations were available for 
statistical comparisons between different time frames at T2 (26 monthsweeks). 
Conversely, horizontal gain could be correctly estimated at T4 in all 17 cases, but 
shrinkage could be calculated only for 14 cases matching with T2 measurements (5 
in the mandible and 9 in the maxilla).
Primary Outcomes
Soft tissue gain after 2 weeks was 1.570.76mm (median 1.53, 95% CI (confidence 
intervals): 1.20, 1.93mm), though a reduction was expected in the first months. Six 
months after soft tissue augmentation, the mean change in horizontal dimension 
respect to T1 was +0.830.64mm (median 0.62, 95%CI: 0.56, 1.11mm) (p<0.01). 
Fifteen out of 23 implants (65.2%) achieved a clinically relevant horizontal gain of 
>0.5 mm. In 5 cases (21.7%) the horizontal gain was >1mm. The highest chance for 
success was observed in the upper posterior jaw (82%; 9 of 11), while in the other 
regions it was 50%. At 24-month follow-up, the horizontal gain averaged 
0.770.65mm (median 0.61, 95%CI: 0.44, 1.11mm), being not significantly different 
from T3 (p=0.19). The gain was >0.5 mm in 64.7% of the cases (in 5 cases (29.4%) it 
was >1mm). Figure 4 is a box-and-whiskers plot showing the horizontal gain at T2, 
T3 and T4. As the data did not follow a Gaussian distribution, non-parametric tests 
were used for comparisons. 
The mean overall horizontal shrinkage of soft tissue observed at T3 and T4, 
compared to the data evaluated at T2, was 34.2%77.0% (median 67%, 95%CI: -3.1, 
71.5%) (p<0.01) and 19.9%96.1% (median 65.3, 95%CI: -31.2, 71.1%), 
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respectively. There was no significant difference in shrinkage between T3 and T4 
(p=0.39), suggesting a fair volume maintenance from 6 to 24 months. The standard 
deviation is rather high, as in some cases a further expansion instead of a shrinkage, 
was observed. Figure 5 compares the shrinkage observed in the posterior maxilla vs 
posterior mandible. The difference in shrinkage between the two posterior regions 
was not statistically significant (p=0.23 and p=0.36 at 6 and 24 months, respectively). 
The two cases located in the anterior region of the maxilla (both were lateral incisors) 
were excluded from such comparison. Such cases showed a rather high shrinkage at 
T3, equal to 74% and 66.5%. Such values remained essentially unchanged at T4.
Secondary Outcomes
No adverse event such as dehiscence, post-measurement infection or bleeding was 
recorded at any time.
Discussion
In the present prospective multi-center case series, we aimed to assess 1) the 
possibility to augment the horizontal ridge dimension by using an APDM during 
second stage implant surgery and 2) how much graft shrinkage needs to be expected 
6-month post-surgery. 
 The main limitation of this study could be considered the absence of a control group. 
The latter, with just repositioning of the flap, could certainly have added value to this 
study, and possibly confirm that the observed results were dependent on the 
application of APDM. Ideally, each test site should have a matched control, with 
similar anatomical and morphological features, which may not be as easy to find. 
Furthermore, the sample size is limited, especially if comparisons between different 
jaw regions (requiring data split into subgroups) are to be made. Also, though a 
multicenter study design may allow to recruit a larger number of patients in a 
relatively short time, one has to consider possible differences in patient management 
and prosthetic protocols among different centrescenters. Given the similar 
experiencetise of the surgeons, and their specific training on the procedures used in 
this study, it was assumed that there was no relevant inter-operator difference. This 
implies a rather poor standardization among cases. Finally, no specific clinical 
parameters like plaque index, soft tissue bleeding or inflammation, that might play a 
role in affecting tissue volume, were not systematically measured in the different 
centrescenters. So, this may be considered a pilot study, whose results need to be 
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confirmed by further prospective studies. Within the limitations of this case series, it 
seems to be possible to predictably gain at least 0.5 mm of soft tissue in the 
horizontal dimension applying an APDM during second stage surgery, especially in 
the posterior maxilla, where in a few cases even more than 2 mm augmentation were 
observed at 6 months. Defects in the mandible, anterior sites and free-end situations 
seem to be less favorable. We underline that the flap at second stage was not 
buccally repositioned but it was only closely adapted to the healing abutment, and 
the observed increase in thickness was likely only due to the porcine dermal matrix. 
When using this technique, “graft” shrinkage of around 30-40% may occur after 6 
months, depending on the location of surgery. The quite variable shrinkage observed 
(Fig. 4), and the fact that in some cases an expansion occurred between T2 and T3 
deserves further studies with larger sample size to investigate the factors that may 
affect augmentation prognosis. SoTherefore, this may be considered a pilot study, 
whose results need to be confirmed by further prospective studies.
Mucosal thickness is an important factor regarding esthetics and long-term tissue 
stability. The difference in light reflection (translucency) of soft tissue covering 
titanium or zirconia abutments is no longer noticeable for the human eye when the 
mucosa thickness exceeds 2 mm.32
Multiple pre-clinical investigations regarding the effectiveness and safety of different 
soft tissue substitutes have been published, focusing on graft integration and 
dimensional changes.20,27,30-33 One of the major concern of such studies was to 
determine to what extent xenograft collagen matrices would be resorbed by the host, 
namely the soft tissue gain stability along time. One animal study showed that the 
gain in volume is rather stable after a few months.22 The authors concluded that in 
spite of the degradation of the xenograft, which leads to a significant amount of 
volume loss, part of the collagen matrix may remain, or being replaced by newly 
formed connective tissue.22 
In a split-mouth study, Fickl et al. compared SCTG and APDM for the treatment of 
buccal dehiscence defects at upper canines in five dogs.34 After 4-month follow-up, 
they found no statistical significant difference neither in soft tissue height nor 
thickness and, thereby, concluded that the applied APDM might be a valid alternative 
to autologous grafts. Schmitt et al. used a similar pre-clinical model applying another 
type of APDM.21 The mean horizontal gain was 0.65 mm for SCTG and 0.96 mm for 
APDM directly after surgery, however, after 10 months, only 0.13 mm for SCTG and 
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0.01 mm for residual APDM, showing a net tissue loss. In 2010, Thoma et al. 
evaluated a porous collagen matrix (CM) for volumetric augmentation in chronic ridge 
defects in dogs.22 While they used a 5 mm thick CM folded twice, they gained 1.4 
mm in thickness after 84 days. They found similar results for SCTG folded twice – 5 
mm thick before removal of epithelium remnants, fatty & glandular tissue - and CM 
after 28 and 84 days. However, they did not report on the volumetric gain directly 
after surgery, which would have been interesting to evaluate graft shrinkage. More 
recently, the same group used a similar cross-linked, porous CM for soft tissue 
augmentation after bone grafting using guided-bone-regeneration.35 While the 
achieved dimensional gain was stable for the first two months, a significant loss was 
observed in the following four months. Only a minimal gain of 0.55 mm for the SCTG 
and 0.23 mm for CM was noted in the most coronal aspect compared to 2.5 mm 
(SCTG) and 2.1 mm (CM) after 1 month, while around 50% of the tissue gain (SCTG: 
0.64 mm, CM: 0.68 mm; p = 0.98) was maintained at the level of implant shoulder. 
The observed dimensional gain in our study population using a 2-mm thick and rather 
dense APDM might be comparable to the above reported results using a thicker, 
porous CM. It remains unclear whether a more porous – and maybe more prone to 
compression - or a denser structure of soft tissue substitutes is more favorable 
regarding long-term stability.
Clinically, Puisys & Linkevicius showed that mucosal thickness around dental 
implants can be successfully increased with an ADM of allogenic origin with 
concomitant reduction of bone loss compared to untreated cases with thin 
tissues.36,37 Allogenic ADM was also used to correct horizontal ridge defects before 
prosthetic rehabilitation.38 About 40% horizontal volume loss was observed, with the 
highest change occurring within the first 3 months. It was concluded that allogenic 
ADM may be a suitable material for the treatment of soft tissue ridge deformities due 
to its biocompatibility, color matching and horizontal gain. However, only in few cases 
was the desired tissue gain achieved.38 De Bruyckere et al. used SCTG to correct 
horizontal alveolar defects around single implants in the anterior maxilla.39 Horizontal 
tissue thickness gain averaged 0.97, mm equivalent to 90.5% of the gain observed 
immediately after SCTG placement. This represents one of the lowest reported tissue 
loss after soft tissue augmentation. In that study, however, all implants had been 
restored with screw-retained provisional, as opposed to our cases and the majority of 
reports in literature.
Page 16 of 28Clinical Implant Dentistry and Related Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
As previously said, the major limitation of the present clinical study is the lack of a 
control group. SCTG is still seen as the gold-standard and could have been served 
as a control, however, it is complicated to standardize graft thickness and 
composition (connective vs. fatty/glandular tissue), especially in a multi-center study. 
Also, as SCTG is an operator-sensitive technique, the variability introduced by the 
different operators involved should have been taken into account. 
The present preliminary data confirmed that using acellular porcine dermal matrix, a 
soft tissue augmentation greater than 0.5mm may be achieved after 6 months of 
follow-up, and maintained up to 2 years, in two-thirds of cases. Future studies should 
aim at providing clear indication of possible achievements and limitations of 
substitutes used for soft tissue augmentation in the clinical practice. These studies 
should focus on the comparison of collagen matrices with different features (e.g. 
xenogenic versus allogenic origin, or dense versus porous structure), in order to give 
recommendations for the proper indication and use of these materials as a feasible 
alternative to autologous grafts. Standardized research protocols should be 
established to allow comparison of different studies. 
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Figure legends
Figure 1. a) atop left:. Clinical case of a female patient of 55 years, rehabilitated with 
an implant placed in the upper left lateral incisor site. Initial situation at uncovering 
(T0), with the implant placed in region 22 and the adhesive bridge, splinted to 
adjacent teeth; b) .
btop right.: Horizontal defect soon before second stage surgery. The oOcclusal view 
showings insufficient contour profile, in need for augmentation;. Horizontal defect 
before second stage surgery
c.) middle left: Augmentation of the soft tissue with dermal matrix; 
d.) middle right: Occlusal view soon after suturing, at the end of surgery (T1); 
e) bottom left:. Clinical situation 2 weeks post-surgery (T2); 
f.) bottom right: Buccal view of the caseBuccal view of the case two years after 
surgery (T4). In spite of a light tissue shrinking, the patient expressed full satisfaction.
 Clinical occlusal view of a 42-year old male patient, rehabilitated with an implant 
placed at upper left second premolar site. a) Pre-surgical clinical view, note the 
buccal contour invagination before 2nd stage surgery; b) acellular porcine dermal 
matrix (APDM) in place after split-flap preparation on the buccal aspect; c) Post-
surgical view after flap closure, care was taken to completely cover the ADM; d) After 
6 months, nearly complete maintenance of the augmented volume with healthy peri-
implant tissues.
Figure 2. Clinical occlusal pictures of a male patient of 33 years, that was 
rehabilitated through a submerged implant placed in the upper right first premolar 
site. a) top panel, left: pre-surgical clinical view (T0), note the vestibular contour 
invagination before 2nd stage surgery; b) top, right: Post-surgical view after flap 
closure (T1), care was taken to completely cover the APDM; c) bottom panel, left: 
Primary soft tissue healing: note the relevant gain in vestibular contour volume 14 
days after surgery (T2); d) bottom, right: After 6 months follow-up, nearly complete 
maintenance of the augmented volume with healthy peri-implant tissues is observed 
(T3).
Figure 3. Top images: digital reconstruction of casts of the clinical case shown in Fig. 
1, taken at T0, T2, T3, T4. Bottom images: examples of analysis of the volume gain, 
obtained by overlapping two digital reconstructions. From left to right: T2-T0, T3-T0, 
T4-T0.
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Figure 4. Whiskers box plots of the horizontal dimensional gain at 2 weeks (T2), 6 
months (T3) and 24 months (T4) after soft tissue augmentation. Median values 
(horizontal black lines) and mean values (crosses) are shown, with the 25th and 75th 
percentiles outline by the box plot. Vertical lines with horizontal bars extend to the 
95% confidence intervals (C.I.). Values outside 95% C.I. are shown (hollow circles). 
The Wilcoxon matched-pairs signed rank test showed statistically significant 
difference at T3 respect to T2 (p=0.001), while no significant difference was found 
between T2 and T3 (p=0.19), indicating good maintenance.
Figure 5. Whiskers box plots of the soft tissue shrinkage between T2 (2 weeks post-
augmentation) and T3 (6-month follow-up), and between T2 and T4 (24-month 
follow-up) in cases located in the posterior mandible (n=5) and in the posterior 
maxilla (n=9). Negative values indicate expansion. Median values (horizontal black 
lines) and mean values (crosses) are shown, with the 25th and 75th percentiles 
outline by the box plot. Vertical lines with horizontal bars extend to the 95% 
confidence intervals (C.I.). Values outside 95% C.I. are shown (hollow circles). The 
Mann Whitney test showed non-significant difference in shrinkage between posterior 
arches (p=0.22). Variability tended to increase with follow-up time.
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Figure 1. a) top left: Clinical case of a female patient of 55 years, rehabilitated with an implant placed in the 
upper left lateral incisor site. Initial situation at uncovering (T0), with the implant placed in region 22 and 
the adhesive bridge, splinted to adjacent teeth; b) top right: Horizontal defect soon before second stage 
surgery. The occlusal view shows insufficient contour profile, in need for augmentation; c) middle left: 
Augmentation of the soft tissue with dermal matrix; d) middle right: Occlusal view soon after suturing, at 
the end of surgery (T1); e) bottom left: Clinical situation 2 weeks post-surgery (T2); f) bottom right: Buccal 
view of the case two years after surgery (T4). In spite of a light tissue shrinking, the patient expressed full 
satisfaction. 
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Figure 2. Clinical occlusal pictures of a male patient of 33 years, that was rehabilitated through a submerged 
implant placed in the upper right first premolar sit . a) top panel, left: pre-surgical clinical view (T0), note 
the vestibular contour invagination before 2nd stage surgery; b) top, right: Post-surgical view after flap 
closure (T1), care was taken to completely cover the APDM; c) bottom panel, left: Primary soft tissue 
healing: note the relevant gain in vestibular contour volume 14 days after surgery (T2); d) bottom, right: 
After 6 months follow-up, nearly complete maintenance of the augmented volume with healthy peri-implant 
tissues is observed (T3). 
85x57mm (300 x 300 DPI) 
Page 26 of 28Clinical Implant Dentistry and Related Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
 
Figure 3. Top images: digital reconstruction of casts of the clinical case shown in Fig. 2, taken at T0, T2, T3, 
T4. Bottom images: examples of analysis of the volume gain, obtained by overlapping two digital 
reconstructions. From left to right: T2-T0, T3-T0, T4-T0. 
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Figure 4. Whiskers box plots of the horizontal dimensional gain at 2 weeks (T2), 6 months (T3) and 24 
months (T4) after soft tissue augmentation. Median values (horizontal black lines) and mean values 
(crosses) are shown, with the 25th and 75th percentiles outline by the box plot. Vertical lines with horizontal 
bars extend to the 95% confidence intervals (C.I.). Values outside 95% C.I. are shown (hollow circles). The 
Wilcoxon matched-pairs signed rank test showed statistically significant difference at T3 respect to T2 
(p=0.001), while no significant difference was found between T2 and T3 (p=0.19), indicating good 
maintenance. 
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Figure 5. Whiskers box plots of the soft tissue shrinkage between T2 (2 weeks post-augmentation) and T3 
(6-month follow-up), and between T2 and T4 (24-month follow-up) in cases located in the posterior 
mandible (n=5) and in the posterior maxilla (n=9). Negative values indicate expansion. Median values 
(horizontal black lines) and mean values (crosses) are shown, with the 25th and 75th percentiles outline by 
the box plot. Vertical lines with horizontal bars extend to the 95% confidence intervals (C.I.). Values outside 
95% C.I. are shown (hollow circles). The Mann Whitney test showed non-significant difference in shrinkage 
between posterior arches (p=0.22). Variability tended to increase with follow-up time. 
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